{"id":4804,"date":"2013-02-22T12:41:34","date_gmt":"2013-02-22T20:41:34","guid":{"rendered":"http:\/\/www.pixelube.com\/work\/c4c\/?p=4804"},"modified":"2013-02-22T12:41:34","modified_gmt":"2013-02-22T20:41:34","slug":"uw-professor-jim-olsens-start-up-company-blaze-bioscience-raises-8-5m-to-help-surgeons-pinpoint-cancer-with-tumor-paint","status":"publish","type":"post","link":"https:\/\/www.pixelube.com\/work\/c4c\/uw-professor-jim-olsens-start-up-company-blaze-bioscience-raises-8-5m-to-help-surgeons-pinpoint-cancer-with-tumor-paint\/","title":{"rendered":"UW Professor Jim Olson&#039;s start-up company Blaze Bioscience Raises $8.5M to help surgeons pinpoint cancer with &quot;tumor paint&quot;"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.pixelube.com\/work\/c4c\/wp-content\/uploads\/2013\/02\/Blaze-brain-image.jpg\" alt=\"\" title=\"Blaze-brain-image\" width=\"251\" height=\"251\" class=\"alignright size-full wp-image-4806\" \/>Seattle biotechnology start-up <a href=\"http:\/\/www.blazebioscience.com\/\" target=\"_blank\">Blaze Bioscience<\/a> has raised $8.5 million to continue developing technologies that are designed to help surgeons more easily identify cancer cells in the body. Total funding in the company now stands at $9.8 million. Blaze said that the money came from individual investors, including doctors and biotech execs.<\/p>\n<p>Blaze&#8217;s Tumor Paint technology is designed to provide real-time, high-resolution visualization of cancer cells, enabling better detection and more complete and precise surgical removal of cancer. The first product, which is a combination of a targeting peptide and a fluorescent beacon, is under development for cancer surgery in multiple solid tumor types.<\/p>\n<p>The funding will support the advancement of Blaze\u2019s Tumor Paint product and the expansion of Blaze\u2019s leadership team and establishment of a corporate headquarters, including laboratory space, in the South Lake Union area of Seattle.<\/p>\n<p>Blaze was co-founded by <a href=\"http:\/\/depts.washington.edu\/behneuro\/people\/faculty\/olson.shtml\" target=\"_blank\">Jim Olson<\/a>, a pediatric neuro-oncologist at <a href=\"http:\/\/www.seattlechildrens.org\/\" target=\"_blank\">Seattle Children\u2019s Hospital<\/a>, a member of the <a href=\"http:\/\/www.fhcrc.org\/en.html\" target=\"_blank\">Fred Hutchinson Cancer Research Center<\/a> and a Professor at the <a href=\"http:\/\/www.uwmedicine.org\/Pages\/default.aspx\" target=\"_blank\">University of Washington\u2019s School of Medicine<\/a>. Blaze is a Fred Hutchinson spin-out and the technology was initiated under a grant with three researchers: Olson, Rich Ellenbogen of UW and Seattle Children&#8217;s Hospital, and Miqin Zhang of UW. Following the initial grant, the follow up work on the intellectual property that Blaze has licensed was developed at Fred Hutchinson.<\/p>\n<p><strong><\/p>\n<hr \/>\n<p><\/strong><\/p>\n<p><strong>Media coverage<\/strong>:<\/p>\n<p>Xconomy Seattle: <a href=\"http:\/\/www.xconomy.com\/seattle\/2013\/02\/22\/blaze-bioscience-caps-off-8-5m-financing-charges-toward-clinic\/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=blaze-bioscience-caps-off-8-5m-financing-charges-toward-clinic\" target=\"_blank\">&#8220;Bioscience Caps Off $8.5M Financing, Charges Toward Clinic&#8221;<\/a><\/p>\n<p>Geekwire: <a href=\"http:\/\/www.geekwire.com\/2013\/blaze-bioscience-raises-85m-surgeons-pinpoint-cancer-tumor-paint\/#utm_source=GeekWire+Daily+Digest&#038;utm_medium=email&#038;utm_campaign=17d7eb1530-daily-digest-email\" target=\"_blank\">&#8220;Blaze Bioscience raises $8.5M to help surgeons pinpoint cancer cells with \u2018tumor paint\u2019&#8221;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seattle biotechnology start-up Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more easily identify cancer cells in the body. Total funding in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-4804","post","type-post","status-publish","format-standard","hentry","category-startup-news"],"_links":{"self":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/posts\/4804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/comments?post=4804"}],"version-history":[{"count":0,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/posts\/4804\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/media?parent=4804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/categories?post=4804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pixelube.com\/work\/c4c\/wp-json\/wp\/v2\/tags?post=4804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}